- Zacks via Yahoo FinanceOct 09 15:10 PM
Swiss pharma giant Novartis AG NVS announced that the FDA approved its ophthalmology drug Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration ...
Nasal Sprays Market Size, Top 3 Players Operating Players | ADAPT Pharma, Inc., Egalet Corporation, GlaxoSmithKline plc. and moreMarket Watch15 hours ago
- Market Watch6 days ago
- Market Watch5 days ago
- Zacks via Yahoo FinanceOct 14 14:15 PM
Novartis claims that this anti-VEGF therapy offers greater fluid resolution as compared to Regeneron/Bayer's market-leading drug Eylea.
- Zacks via Yahoo FinanceOct 10 14:11 PM
The recent FDA approval of Novartis AG’s NVS Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration (AMD) has put the spotlight on this promising space ...
- Zacks via Yahoo FinanceOct 11 15:03 PM
This week, the FDA approved Novartis' NVS potential blockbuster eye drug, Beovu. J&J JNJ submitted a regulatory application seeking label expansion approval of its plaque psoriasis drug, Stelara ...
- related to Bayer Pharma AG